Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen
Xinhua Wang(Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Ken H. Young(Duke Medical Center), Xiangli Liu(First Affiliated Hospital of Zhengzhou University), Liqun Zou(Sichuan University), Wencai Li(First Affiliated Hospital of Zhengzhou University), Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Xin Li(China Medical University), Lei Zhang(Union Hospital), Hong‐Wei Xue(South China Agricultural University), Jingjing Wu(Beijing Tian Tan Hospital), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Liping Su, Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Yanzhen Guo(First Affiliated Hospital of Henan University of Science and Technology), Jinghua Wang(Beijing Tongren Hospital), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Tian Li(Xuzhou Central Hospital), Yi Lu(Xinxiang Central Hospital), Zhi‐Yuan Zhou(Tsinghua University)
Cited by 16
Related Papers
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|682
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418